반응식
[CH:1]1[C:6]([C:7]2[CH:12]=[CH:11][C:10]([C:13]([OH:15])=O)=[CH:9][CH:8]=2)=[CH:5][CH:4]=[C:3]([C:16]([OH:18])=O)[CH:2]=1.[NH2:19][C:20]1[CH:29]=[CH:28][C:23]2[N:24]=[C:25]([Cl:27])[NH:26][C:22]=2[CH:21]=1>>[Cl:27][C:25]1[NH:24][C:23]2[CH:28]=[CH:29][C:20]([NH:19][C:13]([C:10]3[CH:9]=[CH:8][C:7]([C:6]4[CH:1]=[CH:2][C:3]([C:16]([NH:19][C:20]5[CH:29]=[CH:28][C:23]6[NH:24][C:25]([Cl:27])=[N:26][C:22]=6[CH:21]=5)=[O:18])=[CH:4][CH:5]=4)=[CH:12][CH:11]=3)=[O:15])=[CH:21][C:22]=2[N:26]=1참가 물질
3
실험 절차
Compound 285 was prepared according to the procedure similar to that described in Scheme V from 4,4′-bisbenzoic acid and 5-amino-2-chlorobenzimidazole. [M+H]+ calcd for C28H18N6O2: 541.09; found: 541.91.
출처 및 근거
- ORD 기록
- ord-fc5b59062dfb42d9858bd50aa5d298bc
- 출처 데이터셋
- uspto-grants-2015_09
- 특허 번호
- US09144557B2
연결된 노트
불러오는 중…